Our results showed that the levels of IL-2<sup>+</sup>, IL-6<sup>+</sup>, IL-9<sup>+</sup>, IFN-γ<sup>+</sup>, and TNF-α<sup>+</sup> were significantly lower, whereas the levels of TGF-β<sup>+</sup> in the spleen and in splenic CD4<sup>+</sup> T cells were significantly higher in the CGS-treated mice than in the BTBR control and SCH-treated mice.